JATT II Acquisition Acquisition | Healthcare Deal in NJ

JATT II Acquisition Corp has completed the acquisition of a healthcare services other business in New Jersey, for $60,000,000. The platform acquisition is structured as a Cayman Islands exempted special purpose acquisition company targeting healthcare M&A opportunities across healthcare services other. The search fund acquisition approach supports NJ acquisitions by positioning the vehicle to pursue healthcare deals NJ and identify operating targets for future combination. The announced initial public offering priced 6,000,000 ordinary shares at $10.00 each, with an over-allotment option for up to 900,000 additional shares, and trading on Nasdaq Global Market under ticker JATT expected to begin April 17, 2026, with closing expected April 20, 2026.